Long-Term Meditation May Reduce Stress And Aging, Study Suggests
Meditating can help you relax in the short term, but if you stick with it, it might also steel you against the effects of chronic stress and aging, a new study finds.
Researchers examined gene expression, cognitive function, and hair cortisol levels in people who have been practicing Transcendental Meditation (TM) for either 12 or 40 years.
Compared to control groups of similarly aged people who don't meditate, those with four decades of experience practicing TM showed reduced biomarkers for chronic stress and biological aging.
"The lower expression of age-related genes and lower hair cortisol in the TM groups extend the findings of short-term studies indicating these practices lead to healthy aging and more resilient adaptation to stress," says physiologist Kenneth Walton from Maharishi International University in the US.
TM has ancient origins in the Vedic religious tradition of India, but the modern incarnation was developed and popularized in the 20th century by spiritual leader Maharishi Mahesh Yogi, commonly known as the Maharishi.
The method involves silent repetition of a personal mantra during two daily 20-minute sessions. Certified instructors follow a standardized system created by the Maharishi to teach TM techniques, sometimes called technologies of consciousness.
"This study provides evidence that long-term practice of TM technologies has a broad range of health benefits at the molecular level," says molecular physiologist Supaya Wenuganen, from Maharishi International University (MIU), which was founded by the Maharishi in 1971.
In previous research, Wenuganen and colleagues found 200 differentially expressed genes between TM practitioners and non-meditators. Suspecting potential health benefits from those discrepancies, they sought to learn more with their new investigation.
The expression of genes linked with inflammation and aging was lower in TM practitioners, the new study found. That includes the SOCS3 gene, which is associated with chronic stress as well as energy metabolism.
The reduced expression of these genes suggests people who meditate may carry a lighter allostatic load, or the cumulative effects caused by chronic stress.
The results also fit with previous findings suggesting TM can improve energy metabolism efficiency.
However, it's important to note these findings don't show direct cause and effect. Those who practice TM may also be more likely to possess another unknown trait that's responsible for the associated benefits, or to be generally more health-conscious, than those who don't practice.
The researchers used electroencephalogram (EEG) recordings to look at cognitive function, another variable known to decline with age. The findings revealed that older TM practitioners had cognitive processing speeds similar to those of younger subjects.
Long-term practitioners of TM also scored higher on the "Brain Integration Scale" (BIS), a metric designed to encompass various cognitive abilities such as attention and reaction time.
"The findings around cognitive function are particularly exciting," says biopsychologist Frederick Travis of MIU. "Both younger and older TM practitioners showed higher scores on the BIS compared to non-meditators. The older meditators performed on par with young controls."
"This reinforces the findings on evoked potential responses," he adds, "further suggesting a protective effect against cognitive decline with age."
The researchers measured hair concentrations of the steroid hormone cortisol along with its inactive precursor, cortisone, finding the ratio of active to inactive forms was lower among TM practitioners than non-meditators.
This too hints at lower stress levels, and supports other findings that link regular TM practice with reduced stress.
"Cortisol plays a critical role in the body's response to stress, and chronically high cortisol levels are associated with a host of age-related health issues in addition to cognitive decline," Walton says.
"The reduced cortisol-to-cortisone ratio in meditators suggests they have more adaptive reserve, more resilience, contributing to overall health and longevity."
The study was published in Biomolecules.
This Traditional African Diet Appears to Boost The Immune System
'Misokinesia' Phenomenon Could Affect 1 in 3 People, Study Shows
Scientists Discover a Simple Method to Reduce Mercury Levels in Tuna
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
How Coffee Affects Your Sleeping Brain – and Why Young Adults Are Worse Off
In a new study published in the journal Nature Communications Biology, a team of researchers explored how caffeine affects sleep and brain recovery – physically and cognitively – overnight. The team studied a total of 40 healthy adults, whose brain activity was measured on two separate nights: one when they consumed caffeine capsules three hours and one hour before bedtime (totalling 200mg caffeine), and another when they took a placebo at the same times. The scientists then used AI and electroencephalography (EEG) to study the participants' nocturnal brain activity to see how caffeine affected their sleep. Following their statistical analysis, the researchers found that caffeine increased the complexity of the participants' brain signals, making them more dynamic and less predictable – particularly during the non-rapid eye movement (NREM) phase of sleep, which is crucial for memory consolidation and cognitive recovery. They also identified changes in the brain's electrical signals during sleep. Namely, that caffeine led to slower oscillations (such as theta and alpha waves, which are generally associated with deep, restorative sleep) and stimulated beta wave activity – seen more during wakefulness and mental engagement. 'These changes suggest that even during sleep, the brain remains in a more activated, less restorative state under the influence of caffeine,' said Karim Jerbi, a psychology professor and one of the study's authors. 'This change in the brain's rhythmic activity may help explain why caffeine affects the efficiency with which the brain recovers during the night, with potential consequences for memory processing.' The main thing you need to know is that, according to this study, caffeine increases brain signal complexity and enhances something called your brain 'criticality' during sleep. Jerbi defined this as 'a state of the brain that is balanced between order and chaos'. 'It's like an orchestra: too quiet and nothing happens, too chaotic and there's cacophony. Criticality is the happy medium where brain activity is both organised and flexible. In this state, the brain functions optimally: it can process information efficiently, adapt quickly, learn and make decisions with agility.' When we drink coffee, the brain is stimulated and pushed into a state of criticality – where it's more awake, alert and reactive. 'While this is useful during the day for concentration, this state could interfere with rest at night: the brain would neither relax nor recover properly,' explained Julie Carrier, a sleep and ageing professor whose team collaborated with the researchers on this study. To ensure your brain gets ample recovery time while you sleep, it could mean reconsidering that 4 pm work slump coffee and swapping it for something lower in caffeine or free from it altogether. Government guidelines suggest around 400 mg of caffeine as the upper daily limit. Given that the participants in this study consumed 200 mg in the three hours before bedtime and still experienced increased brain activity during sleep, you might benefit from rethinking your coffee schedule and potentially shifting it to front-load your caffeine in the first half of the day. According to this study, your sleeping brain may be less affected by coffee the older you get. Researchers found that younger adults (aged 20-27) compared to middle-aged participants (41-58) were significantly more affected by caffeine – especially during REM sleep – the phase associated with dreaming. They said this increased response was likely due to a higher density of adenosine (a molecule that gradually accumulates in the brain throughout the day, causing feelings of fatigue) receptors in their brains. 'Adenosine receptors naturally decrease with age, reducing caffeine's ability to block them and improve brain complexity, which may partly explain the reduced effect of caffeine observed in middle-aged participants,' Carrier explained. This was a relatively small study and the researchers highlighted that while it's the first to show that caffeine enhances brain criticality during sleep, more research is needed to confirm the results. Now they've shed light on what happens in the brain after lights out following caffeine consumption, the researchers said more studies are needed to explore how these neural changes might affect people's cognitive health and daily functioning – and to potentially guide personalised recommendations for caffeine intake. Thanks to its antioxidant properties, coffee can have several health benefits, including reduced risk of chronic diseases like heart disease and some types of cancer. So, this isn't to say it's 'bad' for your health. Rather, this study's unique insight into neural activity gives us some things to consider regarding when, why and how we consume caffeine to ensure our brains get the most out of a good night's kip. You Might Also Like The 23 Best Foods to Build Muscle 10 of the Best Waterproof Boots to Buy in 2019 6 Ways to Improve Your Mental Health
Yahoo
4 days ago
- Yahoo
Sussex researchers make world record-breaking discovery
Sussex researchers have made a world record-breaking discovery that could revolutionise brain scanning. The team at the University of Sussex has developed a technique to detect tiny electrical fields 100 times more effectively than current methods. This discovery, published in Nature Physics, has the potential to significantly improve applications in healthcare, defence, underwater detection and communication, and geological prospecting. The technique was initially developed to create more powerful quantum computers, but its potential extends far beyond this. Medical experts suggest it could lead to huge breakthroughs in our understanding of mental illness, including in the treatment of depression and epilepsy, through improved and less intrusive brain imaging. The researchers used a single charged atom inside a vacuum system, combined with a measurement technique they invented, to achieve this feat. This has made the technique around 100 times more powerful than was previously possible. However, the discovery has the potential to be one million times more powerful. Professor Winfried Hensinger, director of the Sussex Centre for Quantum Technologies, said: "We have built a machine that makes use of single charged atoms (ions), capable of unprecedented measurement capability. "We have managed to tame some of the very strange phenomena of quantum physics to create a device that can detect low frequency electric fields with unprecedented sensitivity. "And we recently developed a microchip that could enhance this sensitivity even further by yet another 10,000 times. "Using a different ion species with such a chip could enhance sensitivity indeed by a million times." James Stone, professor of psychiatry at Brighton and Sussex Medical School, said: "It is an exciting discovery – with development it could open the way for much less intrusive and more detailed 3D imaging of electrical activity in the brain, giving the potential to detect which parts of the brain are active in real-time, and potentially giving insights into how thoughts and sensations are represented in the brain. "It could potentially lead to huge breakthroughs in our understanding of consciousness, as well as of mental illness, and may even be useful in neurofeedback treatments for mental health conditions such as obsessive compulsive disorder or depression by allowing people to visualise their brain activity and respond directly to it. "It could also be useful in neurological conditions such as epilepsy – detecting regions of abnormal activity in deeper brain regions than would be possible with existing EEG methods."

Associated Press
4 days ago
- Associated Press
AIML Subsidiary Neural Cloud Signs LOI with Circular Health to License MaxYield(TM) ECG Signal Processing
Letter of Intent: Circular Health Limited to Enhance ECG Smart Ring with AI-Powered Signal Clarity with multi‑year, per‑user SaaS license targeting commercial launch by September 2025. Global growth catalyst: The collaboration positions both companies to scale AI‑enhanced cardiac monitoring and next-gen health intelligence across new geographies and device form factors. Economic and Clinical Benefits: MaxYield(TM) is expected to improve ECG signal quality, increase the amount of usable data, and provide deeper biometric insights for Circular Health's wearable platform. TORONTO, ON / ACCESS Newswire / June 3, 2025 / AI/ML Innovations Inc. ('AIML' or the 'Company') (CSE: AIML)(OTCQB: AIMLF)(FWB: 42FB) is pleased to announce that its subsidiary Neural Cloud Solutions Inc. has executed a Letter of Intent (LOI) with Circular Health Limited of Paris to integrate and license Neural Cloud's flagship ECG signal‑processing platform, MaxYield™. Circular Health Limited, is a wearable health technology company redefining personalized health with its next-generation smart ring-Circular Ring 2-equipped with ECG capabilities, advanced sensors, and an AI-driven app featuring wellness assistant Kira. This device will offer unique heart rhythm monitoring as part of their mission to empowers users to proactively manage their health. Under the LOI, Circular Health will deploy MaxYield through a cloud-based API during the integration phase leading up to launch. The integration will enable clearer, more interpretable ECG signals and support consumer access to cardiac visualization and insights. The parties intend to finalize a definitive Software License Agreement and target a commercial launch by September 2025. Why MaxYield™ Matters for Circular Health Higher data yield: A cleaner signal allows Circular Health to capture more usable data and enhance measurement precision, unlocking richer biometric insights from every minute of ECG use across its wearable ecosystem. Scalable workflow: The per‑user SaaS model aligns cost with growth, supporting Circular Health's expansion into new geographies and device form factors. Resource redeployment: Automated noise-handling and ECG processing allows clinical and data‑science staff to shift focus from in-house signal cleaning to additional higher‑value analytics and patient engagement. Expansion into New Markets: As MaxYield™ progresses through the FDA 510(k) pipeline, Circular is poised to access additional medically relevant markets, particularly in Remote Patient Monitoring and Clinical Trials. Management Commentary Peter Kendall - President & Chief Commercialization Officer, AIML 'This LOI validates the commercial scalability of MaxYield and our ability to partner with innovative digital‑health companies around the globe. We look forward to helping Circular Health deliver best‑in‑class ECG clarity to its users.' Esmat Naikyar - Chief Product Officer, AIML / President, Neural Cloud Solutions 'By automating the most time‑consuming part of ECG workflows, MaxYield lets Circular Health redeploy resources to deeper analytics and product differentiation. We anticipate that higher‑quality, higher‑volume data will translate into stronger predictive models and better health outcomes.' Laurent Bsalis - Director, Circular Health Limited 'We're excited to collaborate with AIML to bring enhanced ECG signal clarity and comprehensive beat detection to our next-generation ring,' said Laurent Bsalis, Director of Circular Health Limited. 'Together, we aim to redefine what wearable technology can deliver in proactive and personalized health tracking.' For more information about AIML: For detailed information please see AIML's website or the Company's filed documents at . Contact: Blake Fallis (778) 405-0882 [email protected] About AIML Innovations Inc. AIML Innovations Inc. is a global technology company pioneering the use of artificial intelligence and neural networks to transform digital health. Our proprietary platforms leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights-supporting earlier diagnosis, personalized treatment, and more effective care. With a growing portfolio of regulatory filings, including a 510(k) premarket notification and a registered FDA Device Master File, AIML is committed to rigorous validation and broad interoperability. AIML's shares trade on the Canadian Securities Exchange (CSE:AIML), the OTCQB Venture Market (AIMLF), and the Frankfurt Stock Exchange (42FB). On behalf of the Board of Directors: Paul Duffy, Executive Chairman and CEO Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. Forward Looking Statements - Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties, including risks associated with the implementation of the Company's products and services. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including with respect to the nature and timing of future operations and the receipt of all applicable regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. SOURCE: AI/ML Innovations, Inc. press release